Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocryst Pharmaceuticals buy Needham & Company LLC

Biocryst Pharmaceuticals
Start price
€6.67
20.04.23 / 50%
Target price
€12.77
20.04.24
Performance (%)
-38.50%
End price
€4.10
21.04.24
Summary
This prediction ended on 21.04.24 with a price of €4.10. The BUY prediction by Needham___Company_LL for Biocryst Pharmaceuticals performed very badly with a performance of -38.50%. Needham___Company_LL has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Needham___Company_LL has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Biocryst Pharmaceuticals 2.539% 2.539% -14.702%
iShares Core DAX® 0.650% 3.212% 21.634%
iShares Nasdaq 100 1.650% 0.322% 5.422%
iShares Nikkei 225® 1.232% 1.549% 15.333%
iShares S&P 500 1.413% 0.282% 3.125%

Comments by Needham___Company_LL for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -38.50%
Target price 12.765
Change
Ends at 20.04.24

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat

Needham & Company LLC 
0
Report Share
20.04.23
In the thread Trading Biocryst Pharmaceuticals
Prediction Buy
Perf. (%) -38.50%
Target price 12.765
Change
Ends at 20.04.24

Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten

Needham & Company LLC 
0
Report Share
21.04.24

Current prediction by Needham___Company_LL for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€7.73
13.01.25
€14.69
13.01.26
-17.40%
23.12.25

Needham & Company LLC 
13.01.25 50%

Stopped prediction by Needham___Company_LL for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€5.70
04.11.25
€15.64
04.11.26
12.00%
23.12.25

Needham & Company LLC 
04.11.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€5.62
15.10.25
€17.21
15.10.26
13.52%
23.12.25

Needham & Company LLC 
15.10.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€8.34
25.06.25
€14.62
25.06.26
-23.50%
23.12.25

Needham & Company LLC 
25.06.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€9.65
06.05.25
€15.05
06.05.26
-33.87%
23.12.25

Needham & Company LLC 
06.05.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€5.44
10.04.25
€13.67
10.04.26
17.32%
23.12.25

Needham & Company LLC 
10.04.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.61
05.11.24
€12.84
05.11.25
-6.99%
06.11.25

Needham & Company LLC 
05.11.24 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€4.98
07.05.24
€11.13
07.05.25
78.99%
08.05.25

Needham & Company LLC 
07.05.24 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.00
08.01.24
€10.95
08.01.25
29.27%
09.01.25

Needham & Company LLC 
08.01.24 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€5.70
06.11.23
€11.17
06.11.24
24.81%
07.11.24

Needham & Company LLC 
06.11.23 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.47
03.08.23
€10.96
03.08.24
-1.24%
04.08.24

Needham & Company LLC 
03.08.23 50%